Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelium-derived relaxing factor (EDRF).

F V DeFeudis

    Agents and Actions
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Endothelium-dependent vasorelaxation involves complex signaling in endothelial and smooth muscle cells. Dysregulation of these pathways may contribute to cardiovascular diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Interactions of verapamil, D 600, flunarizine and nifedipine with cerebral histamine-receptors.

    Neurochemistry international·2010
    Same author

    GABA and "neuro-cardiovascular" mechanisms.

    Neurochemistry international·2010
    Same author

    Central GABA-ergic systems and feeding behavior.

    Neurochemistry international·2010
    Same author

    Separate binding sites in rat brain synaptic membranes for l-cysteine sulfinate and for l-glutamate.

    Neurochemistry international·2010
    Same author

    Do different populations of GABA-receptors exist in the vertebrate CNS?

    Neurochemistry international·2010
    Same author

    Effects of psychoactive agents on GABA binding processes.

    Neurochemistry international·2010
    Same journal

    Classification and biological distribution of histamine receptor sub-types. 1975.

    Agents and actions·1994
    Same journal

    Metiamide--an orally active histamine H2-receptor antagonist. 1973.

    Agents and actions·1994
    Same journal

    A brief survey of the history of inflammation. 1978.

    Agents and actions·1994
    Same journal

    The discovery of librium. 1972.

    Agents and actions·1994
    Same journal

    Notes and documents concerning the discovery of LSD. 1970.

    Agents and actions·1994
    Same journal

    Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

    Agents and actions·1994
    See all related articles

    Area of Science:

    • Cardiovascular Physiology
    • Cellular Signaling

    Background:

    • Endothelium-dependent vasorelaxation is crucial for vascular homeostasis.
    • Previous research has identified key molecular events in this process.

    Purpose of the Study:

    • To review and analyze the mechanisms of endothelium-dependent vasorelaxation.
    • To explore the potential role of these mechanisms in cardiovascular disorders.

    Main Methods:

    • Literature review and analysis of recent studies.
    • Examination of signaling pathways in endothelial and smooth muscle cells.

    Main Results:

    • Endothelial cell processes: receptor activation, phospholipase activation, intracellular Ca2+ mobilization, and endothelium-derived relaxing factor(s) (EDRF) synthesis/release.

    Related Experiment Videos

  • Smooth muscle cell processes: guanyl cyclase and protein kinase activation, protein phosphorylation/dephosphorylation, leading to relaxation.

    • Conclusions:

    • Endothelium-dependent vasorelaxation is a multi-step process involving coordinated cellular signaling.
    • Alterations in these signaling pathways are implicated in the pathogenesis of cardiovascular disorders.